EMVision Medical Devices to Present at Australia Investor Day February 26th
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations at VirtualInvestorConferences.com
SYDNEY, Feb. 24, 2026 (GLOBE NEWSWIRE) -- EMVision Medical Devices Limited (ASX:EMV), based in Sydney, Australia, focused on delivering novel diagnostic devices for stroke and traumatic brain injury patients, today announced that Adam Millhouse, Head of Corporate Strategy and Development, will present live at Australia Investor Day hosted by VirtualInvestorConferences.com and OTC Markets Group, on February 26th, 2026
DATE: February 26th
TIME: 1:45 PM ET
Available for 1x1 meetings: schedule virtual meetings here and in-person meetings here
This will be a live, interactive in-person and online event where investors are invited to ask the company questions in real-time. If you would like to attend in-person, please email greg@otcmarkets.com for an attendee pass. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.
It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.
Learn more about the event at www.virtualinvestorconferences.com.
Recent Company Highlights
- Advancing a pivotal clinical trial for the emu™ in-hospital device to support FDA De Novo clearance, in collaboration with leading U.S. Comprehensive Stroke Centers including Mayo Clinic, Mount Sinai, UTHealth and UCLA Health.
- Conducting multi-setting pre-hospital studies of the second-generation ‘First Responder’ device across Australian road, air and mobile stroke services.
- Well capitalised to deliver clinical programs through key regulatory milestones and into commercial readiness.
About EMVision Medical Devices
EMVision Medical Devices Limited (ASX:EMV) is an innovative Australian medical technology company developing and commercializing novel neurodiagnostic devices. Our vision is to help transform and improve the timely diagnosis and treatment of stroke and other time sensitive medical emergencies, such as traumatic brain injury, at the point-of-care. EMVision’s product pipeline includes two portable, non-invasive, safe and affordable neurodiagnostic devices for in-hospital and pre-hospital settings.
About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.
Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.
CONTACTS: EMVision Medical Devices Adam Millhouse Head of Corporate Strategy and Development amillhouse@emvision.com.au Virtual Investor Conferences John M. Viglotti SVP Corporate Services, Investor Access OTC Markets Group (212) 220-2221 johnv@otcmarkets.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
